The patterns of anticoagulation control and the risk of stroke, bleeding and mortality in patients with non-valvular atrial fibrillation: comment
J Thromb Haemost
.
2016 Oct;14(10):2083-2084.
doi: 10.1111/jth.13420.
Epub 2016 Oct 15.
Authors
S Mantha
1
,
S Moll
2
,
P Hilden
3
,
S Devlin
3
,
A Rose
4
Affiliations
1
Hematology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. manthas@mskcc.org.
2
Medicine, University of North Carolina, Chapel Hill, NC, USA.
3
Epidemiology-Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
4
Medicine, Boston University School of Medicine, Boston, MA, USA.
PMID:
27431450
DOI:
10.1111/jth.13420
No abstract available
Publication types
Letter
Comment
MeSH terms
Anticoagulants
Atrial Fibrillation*
Hemorrhage
Humans
Risk Factors
Stroke*
Substances
Anticoagulants
Grants and funding
P30 CA008748/CA/NCI NIH HHS/United States